vs
Side-by-side financial comparison of DYNAVAX TECHNOLOGIES CORP (DVAX) and MID PENN BANCORP INC (MPB). Click either name above to swap in a different company.
DYNAVAX TECHNOLOGIES CORP is the larger business by last-quarter revenue ($94.9M vs $62.0M, roughly 1.5× MID PENN BANCORP INC). MID PENN BANCORP INC runs the higher net margin — 31.4% vs 28.4%, a 3.0% gap on every dollar of revenue. On growth, MID PENN BANCORP INC posted the faster year-over-year revenue change (30.8% vs 17.7%). MID PENN BANCORP INC produced more free cash flow last quarter ($71.8M vs $32.6M). Over the past eight quarters, DYNAVAX TECHNOLOGIES CORP's revenue compounded faster (30.6% CAGR vs 21.1%).
Dynavax Technologies Corp is a commercial-stage biopharmaceutical company specializing in the research, development, and production of innovative vaccines and immunotherapies for infectious diseases. Its lead approved product is Heplisav-B, an adult hepatitis B vaccine, with core markets in North America and Europe, alongside a pipeline of candidates addressing unmet public health needs.
Commerce Bancorp was a Cherry Hill, New Jersey–based bank created in 1973. In 2007, it was purchased by Toronto-Dominion Bank, which merged Commerce into TD Banknorth, the latter of which was rebranded to TD Bank.
DVAX vs MPB — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $94.9M | $62.0M |
| Net Profit | $26.9M | $19.4M |
| Gross Margin | — | — |
| Operating Margin | 22.4% | 43.6% |
| Net Margin | 28.4% | 31.4% |
| Revenue YoY | 17.7% | 30.8% |
| Net Profit YoY | 53.0% | 47.0% |
| EPS (diluted) | $0.21 | $0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $62.0M | ||
| Q3 25 | $94.9M | $61.8M | ||
| Q2 25 | $95.4M | $54.3M | ||
| Q1 25 | $68.2M | $47.7M | ||
| Q4 24 | $72.0M | $47.4M | ||
| Q3 24 | $80.6M | $45.3M | ||
| Q2 24 | $73.8M | $44.1M | ||
| Q1 24 | $50.8M | $42.3M |
| Q4 25 | — | $19.4M | ||
| Q3 25 | $26.9M | $18.3M | ||
| Q2 25 | $18.7M | $4.8M | ||
| Q1 25 | $-96.1M | $13.7M | ||
| Q4 24 | $7.0M | $13.2M | ||
| Q3 24 | $17.6M | $12.3M | ||
| Q2 24 | $11.4M | $11.8M | ||
| Q1 24 | $-8.7M | $12.1M |
| Q4 25 | — | 43.6% | ||
| Q3 25 | 22.4% | 39.3% | ||
| Q2 25 | 15.1% | 7.9% | ||
| Q1 25 | -34.7% | 35.2% | ||
| Q4 24 | -2.3% | 34.1% | ||
| Q3 24 | 12.5% | 32.8% | ||
| Q2 24 | 7.0% | 32.4% | ||
| Q1 24 | -35.0% | 34.8% |
| Q4 25 | — | 31.4% | ||
| Q3 25 | 28.4% | 29.6% | ||
| Q2 25 | 19.6% | 8.8% | ||
| Q1 25 | -141.0% | 28.8% | ||
| Q4 24 | 9.8% | 27.9% | ||
| Q3 24 | 21.8% | 27.1% | ||
| Q2 24 | 15.4% | 26.7% | ||
| Q1 24 | -17.2% | 28.7% |
| Q4 25 | — | $0.83 | ||
| Q3 25 | $0.21 | $0.79 | ||
| Q2 25 | $0.14 | $0.22 | ||
| Q1 25 | $-0.77 | $0.71 | ||
| Q4 24 | $0.07 | $0.72 | ||
| Q3 24 | $0.12 | $0.74 | ||
| Q2 24 | $0.08 | $0.71 | ||
| Q1 24 | $-0.07 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $160.2M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $534.1M | $814.1M |
| Total Assets | $946.5M | $6.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $160.2M | — | ||
| Q2 25 | $99.1M | — | ||
| Q1 25 | $51.7M | — | ||
| Q4 24 | $95.9M | — | ||
| Q3 24 | $119.3M | — | ||
| Q2 24 | $112.5M | — | ||
| Q1 24 | $132.0M | — |
| Q4 25 | — | $814.1M | ||
| Q3 25 | $534.1M | $796.3M | ||
| Q2 25 | $494.2M | $775.7M | ||
| Q1 25 | $530.9M | $667.9M | ||
| Q4 24 | $596.8M | $655.0M | ||
| Q3 24 | $681.4M | $573.1M | ||
| Q2 24 | $642.8M | $559.7M | ||
| Q1 24 | $618.5M | $551.0M |
| Q4 25 | — | $6.1B | ||
| Q3 25 | $946.5M | $6.3B | ||
| Q2 25 | $918.4M | $6.4B | ||
| Q1 25 | $945.9M | $5.5B | ||
| Q4 24 | $986.3M | $5.5B | ||
| Q3 24 | $1.1B | $5.5B | ||
| Q2 24 | $1.0B | $5.4B | ||
| Q1 24 | $986.6M | $5.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $33.8M | $80.0M |
| Free Cash FlowOCF − Capex | $32.6M | $71.8M |
| FCF MarginFCF / Revenue | 34.4% | 115.8% |
| Capex IntensityCapex / Revenue | 1.3% | 13.3% |
| Cash ConversionOCF / Net Profit | 1.26× | 4.12× |
| TTM Free Cash FlowTrailing 4 quarters | $80.5M | $132.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $80.0M | ||
| Q3 25 | $33.8M | $26.3M | ||
| Q2 25 | $23.4M | $29.0M | ||
| Q1 25 | $-19.6M | $11.5M | ||
| Q4 24 | $53.0M | $51.4M | ||
| Q3 24 | $19.5M | $16.9M | ||
| Q2 24 | $10.7M | $18.0M | ||
| Q1 24 | $-16.7M | $12.4M |
| Q4 25 | — | $71.8M | ||
| Q3 25 | $32.6M | $24.3M | ||
| Q2 25 | $22.0M | $27.2M | ||
| Q1 25 | $-23.6M | $8.8M | ||
| Q4 24 | $49.5M | $44.5M | ||
| Q3 24 | $18.1M | $16.8M | ||
| Q2 24 | $9.9M | $17.7M | ||
| Q1 24 | $-17.4M | $12.1M |
| Q4 25 | — | 115.8% | ||
| Q3 25 | 34.4% | 39.4% | ||
| Q2 25 | 23.0% | 50.1% | ||
| Q1 25 | -34.6% | 18.4% | ||
| Q4 24 | 68.8% | 93.8% | ||
| Q3 24 | 22.5% | 37.1% | ||
| Q2 24 | 13.5% | 40.2% | ||
| Q1 24 | -34.3% | 28.5% |
| Q4 25 | — | 13.3% | ||
| Q3 25 | 1.3% | 3.1% | ||
| Q2 25 | 1.5% | 3.2% | ||
| Q1 25 | 5.8% | 5.7% | ||
| Q4 24 | 4.8% | 14.6% | ||
| Q3 24 | 1.7% | 0.0% | ||
| Q2 24 | 1.1% | 0.7% | ||
| Q1 24 | 1.5% | 0.8% |
| Q4 25 | — | 4.12× | ||
| Q3 25 | 1.26× | 1.44× | ||
| Q2 25 | 1.25× | 6.08× | ||
| Q1 25 | — | 0.84× | ||
| Q4 24 | 7.52× | 3.88× | ||
| Q3 24 | 1.11× | 1.37× | ||
| Q2 24 | 0.94× | 1.53× | ||
| Q1 24 | — | 1.02× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DVAX
| HEPLISAVB | $90.0M | 95% |
| US Department Of Defense | $4.7M | 5% |
MPB
Segment breakdown not available.
